The role of suprapubic catheter insertion in preventing urinary tract infections following intravesical Botulinum toxin A

Eur J Obstet Gynecol Reprod Biol. 2021 Sep:264:384-385. doi: 10.1016/j.ejogrb.2021.07.019. Epub 2021 Jul 17.

Authors

Adeolu Banjoko¹, Tom Fawcett², Martino Zacche³, Philip Toozs-Hobson⁴

Affiliations

¹ College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
² The University of Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
³ Department of Urogynaecology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK. Electronic address: [email protected].
⁴ Department of Urogynaecology, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.

PMID: 34376300
DOI: 10.1016/j.ejogrb.2021.07.019

No abstract available

Publication types

Letter

MeSH terms

Botulinum Toxins, Type A* / adverse effects
Catheters
Humans
Urinary Bladder, Overactive*
Urinary Catheterization
Urinary Tract Infections* / prevention & control

Substances

Botulinum Toxins, Type A